Trial Profile
Pharmacokinetics and Efficacy of Low- or Standard-dose of Lopinavir/Ritonavir (Kaletra®) in PI-naïve HIV-1 Infected Children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2020
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Lamivudine; Zidovudine
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- 29 Apr 2009 New trial record